ESR1 and breast carcinoma: In particular, we apply our biclustering model to gene expression levels measured in heterogeneous breast cancer tissue samples to recover a co-expression network that is differentially expressed across estrogen receptor positive and negative (ER+ and ER-) samples [43, 44].